🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Spain / NCT04935840
Active, not recruiting Not applicable

Evaluation of the Effect of FertyBiotic Pregnancy in the Metabolic Profile in Pregnant Women

NCT04935840 · tracked via the Priya Life Science Spain tracker
Sponsor
Fertypharm
Phase
Not applicable
Started
2021-05-05
Last updated
2025-12-04

Condition(s) studied

Pregnancy Related

Investigational drug(s) / intervention(s)

FertyBiotic PregnancyControl

FertyBiotic Pregnancy: DHA, folic acid, Iodine, iron, Lactobacillus rhamnosus, Lactobacillus reuterii, magnesium, zinc, vitamin D3, Vitamin C, Vitamin E, Group B vitamins and Biotin

Control: 400 mcg of folic acid

Study summary

The aim of this study is determine the effect of a food supplement with probiotics on metabolic profile and weight gain in pregnant women.

Eligibility

Sex
FEMALE
Min age
35 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Pregnant women * Age: \> 18 years old * BMI \> 25 * Women who have signed the informed consent to participate in the study. * No intention to change their routine physical activity or usual dietary intakes throughout the study Exclusion Criteria: * \> 14 weeks' gestation * Taking food supplements or probiotics * History or current pathology that influence in the study * With major fetal abnormalities * Had used continuous antibiotic therapy for at least 3 months

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Hospital Vithas Medimar Alicante Alicante
Centro Ginecologico Dra. García-Pérez Llantada Zaragoza Zaragoza

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04935840 on ClinicalTrials.gov ↗ ← All trials in Spain